Cas no 1017587-57-3 ((2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane)
(2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane Chemical and Physical Properties
Names and Identifiers
-
- Phenyl 3-O-Allyl-2,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside
- Phenyl 3-O-Allyl-2,4,6-tri-O-benzyl-1-thio-beta-D-galactopyranoside
- (2S,3S,4S,5S,6S)-3,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane
- -<small>D<
- Gal[246Bn,3All]-β-SPh
- SODIUM GLUCOHEPTONATE
- (2R,3R,4R,5R,6R)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane
- (2R,3S,4S,5R,6S)-4-(Allyloxy)-3,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-2H-pyran
- (2R,3S,4S,5R,6S)-3,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane
- T71530
- 1017587-57-3
- CS-0214483
- (2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane
-
- MDL： MFCD11112183
- Inchi： 1S/C36H38O5S/c1-2-23-38-34-33(39-25-29-17-9-4-10-18-29)32(27-37-24-28-15-7-3-8-16-28)41-36(42-31-21-13-6-14-22-31)35(34)40-26-30-19-11-5-12-20-30/h2-22,32-36H,1,23-27H2/t32-,33+,34+,35-,36+/m1/s1
- InChI Key： OZARVANREPUDBF-BVMCXEQJSA-N
- SMILES： S(C1C=CC=CC=1)[C@H]1[C@@H]([C@H]([C@H]([C@@H](COCC2C=CC=CC=2)O1)OCC1C=CC=CC=1)OCC=C)OCC1C=CC=CC=1
Computed Properties
- Exact Mass: 582.24400
- Monoisotopic Mass: 582.24399548g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 42
- Rotatable Bond Count: 15
- Complexity: 726
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 5
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 71.4
- XLogP3: 7
Experimental Properties
- Density: 1.19±0.1 g/cm3 (20 oC 760 Torr),
- Boiling Point: 693.1±55.0 °C at 760 mmHg
- Flash Point: 373.0±31.5 °C
- Solubility: Insuluble (1.3E-4 g/L) (25 oC),
- PSA: 71.45000
- LogP: 7.46240
- Vapor Pressure: 0.0±2.1 mmHg at 25°C
(2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane Security Information
- Signal Word：warning
- Hazard Statement： H303 may be harmful by ingestion +h313 may be harmful by skin contact +h1106 may be harmful by inhalation
- Warning Statement： P264+P280+P305+P351+P338+P337+P108
- Safety Instruction： H303+H313+H110
- Storage Condition：0-10°C
(2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM126728-1g |
(2R,3S,4S,5R,6S)-4-(allyloxy)-3,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-2H-pyran |
1017587-57-3 | 97% | 1g |
$315 | 2021-06-15 | |
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | P1660-1G |
Phenyl 3-O-Allyl-2,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside |
1017587-57-3 | >98.0%(HPLC) | 1g |
￥155.00 | 2024-04-18 | |
| TRC | C380173-10mg |
(2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane |
1017587-57-3 | 10mg |
$ 50.00 | 2022-06-06 | ||
| TRC | C380173-50mg |
(2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane |
1017587-57-3 | 50mg |
$ 95.00 | 2022-06-06 | ||
| TRC | C380173-100mg |
(2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane |
1017587-57-3 | 100mg |
$ 135.00 | 2022-06-06 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | P868186-250mg |
Phenyl 3-O-Allyl-2,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside |
1017587-57-3 | ≥98% | 250mg |
￥466.20 | 2022-09-01 | |
| abcr | AB261766-1 g |
Phenyl 3-O-Allyl-2,4,6-tri-O-benzyl-1-thio-beta-D-galactopyranoside; . |
1017587-57-3 | 1 g |
€469.80 | 2023-07-20 | ||
| abcr | AB261766-1g |
Phenyl 3-O-Allyl-2,4,6-tri-O-benzyl-1-thio-beta-D-galactopyranoside; . |
1017587-57-3 | 1g |
€408.40 | 2025-04-22 | ||
| Chemenu | CM126728-250mg |
(2R,3S,4S,5R,6S)-4-(allyloxy)-3,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-2H-pyran |
1017587-57-3 | 97% | 250mg |
$55 | 2023-03-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | P1660-1g |
(2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane |
1017587-57-3 | 98.0%(LC) | 1g |
￥490.0 | 2022-06-10 |
(2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane Related Literature
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
Additional information on (2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane
Recent Advances in the Study of (2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane (CAS: 1017587-57-3)
The compound (2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane (CAS: 1017587-57-3) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and implications for drug development.
Recent studies have highlighted the compound's role as a key intermediate in the synthesis of complex glycosides and glycoconjugates, which are of particular interest in the development of novel therapeutics. The presence of multiple phenylmethoxy and phenylsulfanyl groups in its structure contributes to its stability and reactivity, making it a valuable building block in organic synthesis. Researchers have successfully utilized this compound in the construction of glycosidic linkages, which are critical for the biological activity of many natural products and pharmaceuticals.
In terms of biological activity, preliminary investigations suggest that (2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane exhibits promising interactions with various enzymes involved in carbohydrate metabolism. Specifically, it has been shown to inhibit certain glycosidases, which play a crucial role in processes such as viral entry and cancer cell metastasis. These findings open new avenues for the development of enzyme inhibitors targeting these pathways.
Moreover, the compound's unique structural features have been exploited in the design of prodrugs and drug delivery systems. Its ability to undergo controlled degradation under physiological conditions makes it an attractive candidate for targeted drug release. Recent studies have demonstrated its potential in enhancing the bioavailability of poorly soluble drugs, thereby improving their therapeutic efficacy.
Despite these promising developments, challenges remain in the large-scale synthesis and optimization of this compound. Researchers are actively exploring more efficient synthetic routes and purification methods to address these issues. Additionally, further in vitro and in vivo studies are needed to fully elucidate its pharmacological profile and safety.
In conclusion, (2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane represents a versatile and valuable tool in chemical biology and drug discovery. Its unique properties and potential applications warrant continued investigation, and future research is expected to uncover even more opportunities for its use in medicine.
1017587-57-3 ((2R,3S,4S,5R,6S)-3,5-Bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyl-4-prop-2-enoxyoxane) Related Products
- 74801-29-9(Phenyl 2,3,4,6-Tetra-O-benzyl-1-thio-b-D-galactopyranoside)
- 807361-40-6(a-L-Galactopyranoside,4-methylphenyl 6-deoxy-2,3,4-tris-O-(phenylmethyl)-1-thio-)
- 62774-37-2(.alpha.-D-Glucopyranoside, phenyl 2,3,4,6-tetrakis-O-(phenylmethyl)-1-thio-)
- 849938-16-5(Phenyl-α-O-benzyl-1-thio-α-L-rhamnopyranoside)
- 129081-01-2(Phenyl 2,3-bis-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside)
- 116501-53-2(Phenyl 2,3,4,6-tetra-O-benzyl-a-D-thiomannopyranoside)
- 38184-10-0(Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside)
- 167612-35-3(Phenyl 2,3,4-Tri-O-benzyl-1-thio-β-L-fucopyranoside)
- 479252-05-6(4-Methylphenyl 2,3,4-tri-o-benzyl-1-thio-β-d-glucopyranoside)
- 231623-55-5(Phenyl 2,3-di-O-benzyl-b-D-thiogalactopyranoside)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier